Assessment and Measurement of Spasticity in MS: State of the Evidence

Cinda L. Hugos, Michelle Cameron

Research output: Contribution to journalReview article

Abstract

Purpose of Review: The purpose of this review is to familiarize the reader with assessments and measurement of spasticity in people with multiple sclerosis (MS). Spasticity affects 60–84% of people with MS, worsening as disability worsens and impacting activity, participation, and quality of life. Spasticity manifests in many ways, including spasms, resistance to passive stretch, pain, and perception of tightness, and can affect muscles throughout the body, making assessment and quantification of spasticity challenging but important. Assessment tools include those quantified by clinicians, instrumentation, and patients. Recent Findings: Most tools for measuring spasticity are based on clinician scoring, were developed many years ago, and have undergone minimal recent advances. More recent developments are patient-reported outcome measures for spasticity, including the Numeric Rating Scale for Spasticity (NRS-S) and the disease-specific Multiple Sclerosis Spasticity Scale-88 (MSSS), and, most recently, imaging through elastography. Summary: MS-related spasticity is common and often disabling. There are various spasticity measurement tools available, each with advantages and limitations. Newer tools are likely to be developed as our understanding of spasticity in MS grows.

Original languageEnglish (US)
Article number79
JournalCurrent neurology and neuroscience reports
Volume19
Issue number10
DOIs
StatePublished - Oct 1 2019

Fingerprint

Multiple Sclerosis
Elasticity Imaging Techniques
Pain Perception
Spasm
Quality of Life
Muscles

Keywords

  • Assessment
  • Measurement
  • Multiple sclerosis
  • Outcomes
  • Spasticity

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Assessment and Measurement of Spasticity in MS : State of the Evidence. / Hugos, Cinda L.; Cameron, Michelle.

In: Current neurology and neuroscience reports, Vol. 19, No. 10, 79, 01.10.2019.

Research output: Contribution to journalReview article

@article{fda97b645fbd4a45aaaa081c2d5d194f,
title = "Assessment and Measurement of Spasticity in MS: State of the Evidence",
abstract = "Purpose of Review: The purpose of this review is to familiarize the reader with assessments and measurement of spasticity in people with multiple sclerosis (MS). Spasticity affects 60–84{\%} of people with MS, worsening as disability worsens and impacting activity, participation, and quality of life. Spasticity manifests in many ways, including spasms, resistance to passive stretch, pain, and perception of tightness, and can affect muscles throughout the body, making assessment and quantification of spasticity challenging but important. Assessment tools include those quantified by clinicians, instrumentation, and patients. Recent Findings: Most tools for measuring spasticity are based on clinician scoring, were developed many years ago, and have undergone minimal recent advances. More recent developments are patient-reported outcome measures for spasticity, including the Numeric Rating Scale for Spasticity (NRS-S) and the disease-specific Multiple Sclerosis Spasticity Scale-88 (MSSS), and, most recently, imaging through elastography. Summary: MS-related spasticity is common and often disabling. There are various spasticity measurement tools available, each with advantages and limitations. Newer tools are likely to be developed as our understanding of spasticity in MS grows.",
keywords = "Assessment, Measurement, Multiple sclerosis, Outcomes, Spasticity",
author = "Hugos, {Cinda L.} and Michelle Cameron",
year = "2019",
month = "10",
day = "1",
doi = "10.1007/s11910-019-0991-2",
language = "English (US)",
volume = "19",
journal = "Current Neurology and Neuroscience Reports",
issn = "1528-4042",
publisher = "Current Medicine Group",
number = "10",

}

TY - JOUR

T1 - Assessment and Measurement of Spasticity in MS

T2 - State of the Evidence

AU - Hugos, Cinda L.

AU - Cameron, Michelle

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Purpose of Review: The purpose of this review is to familiarize the reader with assessments and measurement of spasticity in people with multiple sclerosis (MS). Spasticity affects 60–84% of people with MS, worsening as disability worsens and impacting activity, participation, and quality of life. Spasticity manifests in many ways, including spasms, resistance to passive stretch, pain, and perception of tightness, and can affect muscles throughout the body, making assessment and quantification of spasticity challenging but important. Assessment tools include those quantified by clinicians, instrumentation, and patients. Recent Findings: Most tools for measuring spasticity are based on clinician scoring, were developed many years ago, and have undergone minimal recent advances. More recent developments are patient-reported outcome measures for spasticity, including the Numeric Rating Scale for Spasticity (NRS-S) and the disease-specific Multiple Sclerosis Spasticity Scale-88 (MSSS), and, most recently, imaging through elastography. Summary: MS-related spasticity is common and often disabling. There are various spasticity measurement tools available, each with advantages and limitations. Newer tools are likely to be developed as our understanding of spasticity in MS grows.

AB - Purpose of Review: The purpose of this review is to familiarize the reader with assessments and measurement of spasticity in people with multiple sclerosis (MS). Spasticity affects 60–84% of people with MS, worsening as disability worsens and impacting activity, participation, and quality of life. Spasticity manifests in many ways, including spasms, resistance to passive stretch, pain, and perception of tightness, and can affect muscles throughout the body, making assessment and quantification of spasticity challenging but important. Assessment tools include those quantified by clinicians, instrumentation, and patients. Recent Findings: Most tools for measuring spasticity are based on clinician scoring, were developed many years ago, and have undergone minimal recent advances. More recent developments are patient-reported outcome measures for spasticity, including the Numeric Rating Scale for Spasticity (NRS-S) and the disease-specific Multiple Sclerosis Spasticity Scale-88 (MSSS), and, most recently, imaging through elastography. Summary: MS-related spasticity is common and often disabling. There are various spasticity measurement tools available, each with advantages and limitations. Newer tools are likely to be developed as our understanding of spasticity in MS grows.

KW - Assessment

KW - Measurement

KW - Multiple sclerosis

KW - Outcomes

KW - Spasticity

UR - http://www.scopus.com/inward/record.url?scp=85071657481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071657481&partnerID=8YFLogxK

U2 - 10.1007/s11910-019-0991-2

DO - 10.1007/s11910-019-0991-2

M3 - Review article

C2 - 31471769

AN - SCOPUS:85071657481

VL - 19

JO - Current Neurology and Neuroscience Reports

JF - Current Neurology and Neuroscience Reports

SN - 1528-4042

IS - 10

M1 - 79

ER -